
    
      The purpose of this feasibility study is to demonstrate the performance and safety of the
      Lumen Biomedical, Inc. FiberNet® Embolic Protection System as an adjunctive device during
      carotid artery percutaneous intervention. The feasibility study will involve a maximum of 50
      subjects to be enrolled using the FiberNet® during clinically indicated percutaneous
      intervention of the carotid artery and followed through 30 days post procedure. Subject will
      be enrolled in up to 5 European Investigational Sites. The study is a prospective
      multi-center registry with sequential enrollment of qualified subjects who consent to
      participate and meet all entrance criteria.
    
  